activity
20162025
most citedKey Questions for Modelling COVID-19 Exit Strategies

138 citations · 315 across the 15 of their papers we have counts for

collaborators

16 papers

q-bio.PE2025

Should public health policy exempt cases with low viral load from isolation during an epidemic?: a modelling study

Jiahao Diao, Rebecca H. Chisholm, Nicholas Geard +1

During the COVID-19 pandemic, case isolation emerged as a key non-pharmaceutical intervention in pandemic response. Its effectiveness hinges on the timing of isolation, which is of…

physics.soc-ph2023★ 15 cited

The role of the mathematical sciences in supporting the COVID-19 response in Australia and New Zealand

James M. McCaw, Michael J. Plank

Mathematical modelling has been used to support the response to the COVID-19 pandemic in countries around the world including Australia and New Zealand. Both these countries have f…

physics.soc-ph2023★ 1 cited

Key challenges for the surveillance of respiratory viruses: transitioning out of the acute phase of the SARS-CoV-2 pandemic

Oliver Eales, Michael J. Plank, Benjamin J. Cowling +8

To support the ongoing management of viral respiratory diseases, many countries are moving towards an integrated model of surveillance for SARS-CoV-2, influenza, and other respirat…

q-bio.PE2021

COVID-19 in low-tolerance border quarantine systems: impact of the Delta variant of SARS-CoV-2

Cameron Zachreson, Freya M. Shearer, David J. Price +4

In controlling transmission of COVID-19, the effectiveness of border quarantine strategies is a key concern for jurisdictions in which the local prevalence of disease and immunity…

q-bio.PE2021

Hypnozoite dynamics for Plasmodium vivax malaria: the epidemiological effects of radical cure

Somya Mehra, Eva Stadler, David Khoury +2

Malaria is a mosquito-borne disease with a devastating global impact. Plasmodium vivax is a major cause of human malaria beyond sub-Saharan Africa. Relapsing infections, driven by…

q-bio.PE2021★ 13 cited

An activation-clearance model for Plasmodium vivax malaria

Somya Mehra, James M. McCaw, Mark B. Flegg +2

Malaria is an infectious disease with an immense global health burden. Plasmodium vivax is the most geographically widespread species of malaria. Relapsing infections, caused by th…

q-bio.OT2020★ 138 cited

Key Questions for Modelling COVID-19 Exit Strategies

Robin N Thompson, T Deirdre Hollingsworth, Valerie Isham +40

Combinations of intense non-pharmaceutical interventions ('lockdowns') were introduced in countries worldwide to reduce SARS-CoV-2 transmission. Many governments have begun to impl…

cs.CY2020★ 9 cited

From climate change to pandemics: decision science can help scientists have impact

Christopher M. Baker, Patricia T. Campbell, Iadine Chades +8

Scientific knowledge and advances are a cornerstone of modern society. They improve our understanding of the world we live in and help us navigate global challenges including emerg…

q-bio.PE2017

Sequential infection experiments for quantifying innate and adaptive immunity during influenza infection

Ada W. C. Yan, Sophie G. Zaloumis, Julie A. Simpson +1

Laboratory models are often used to understand the interaction of related pathogens via host immunity. For example, recent experiments where ferrets were exposed to two influenza s…

q-bio.PE2017

Infection-acquired versus vaccine-acquired immunity in an SIRWS model

Tiffany Leung, Barry D Hughes, Federico Frascoli +2

Despite high vaccine coverage, pertussis has re-emerged as a public health concern in many countries. One hypothesis posed for re-emergence is the waning of immunity. In some disea…

q-bio.PE2017★ 12 cited

A mechanistic model quantifies artemisinin-induced parasite growth retardation in blood-stage Plasmodium falciparum infection

Pengxing Cao, Nectarios Klonis, Sophie Zaloumis +6

Falciparum malaria is a major parasitic disease causing widespread morbidity and mortality globally. Artemisinin derivatives---the most effective and widely-used antimalarials that…

q-bio.PE2016★ 26 cited

A biological model of scabies infection dynamics and treatment explains why mass drug administration does not lead to elimination

M. Lydeamore, P. T. Campbell, D. G. Regan +7

Despite a low global prevalence, infections with Sarcoptes scabiei, or scabies, are still common in remote communities such as in northern Australia and the Solomon Islands. Mass d…

q-bio.PE2016★ 15 cited

A dynamic stress model explains the delayed drug effect in artemisinin treatment of Plasmodium falciparum

Pengxing Cao, Nectarios Klonis, Sophie Zaloumis +8

Artemisinin resistance constitutes a major threat to the continued success of control programs for malaria. With alternative antimalarial drugs not yet available, improving our und…

q-bio.CB2016★ 44 cited

On the role of T cells in determining recovery time from influenza virus infection

Pengxing Cao, Zhongfang Wang, Ada W. C. Yan +5

Myriad experiments have identified an important role for T cell response mechanisms in determining recovery from influenza A virus infection. Animal models of influenza…

q-bio.PE2016★ 12 cited

Periodic solutions in an SIRWS model with immune boosting and cross-immunity

Tiffany Leung, Barry D. Hughes, Federico Frascoli +1

Incidence of whooping cough, an infection caused by Bordetella pertussis and Bordetella parapertussis, has been on the rise since the 1980s in many countries. Immunological interac…

q-bio.PE2016★ 30 cited

Modelling cross-reactivity and memory in the cellular adaptive immune response to influenza infection in the host

Ada W. C. Yan, Pengxing Cao, Jane M. Heffernan +5

The cellular adaptive immune response plays a key role in resolving influenza infection. Experiments where individuals are successively infected with different strains within a sho…